Last reviewed · How we verify
LEO 80190 Vehicle
LEO 80190 Vehicle is a topical formulation vehicle designed to enhance dermal delivery of active pharmaceutical ingredients.
LEO 80190 Vehicle is a topical formulation vehicle designed to enhance dermal delivery of active pharmaceutical ingredients. Used for Dermatological conditions (specific indication dependent on active ingredient combined with vehicle).
At a glance
| Generic name | LEO 80190 Vehicle |
|---|---|
| Sponsor | LEO Pharma |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
As a vehicle formulation rather than an active drug, LEO 80190 Vehicle functions as a delivery system to optimize penetration and retention of therapeutic agents in the skin. The specific composition and mechanism of enhancement are proprietary to LEO Pharma and are designed to support efficacy of the active ingredient when combined in a final formulation.
Approved indications
- Dermatological conditions (specific indication dependent on active ingredient combined with vehicle)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LEO 80190 Vehicle CI brief — competitive landscape report
- LEO 80190 Vehicle updates RSS · CI watch RSS
- LEO Pharma portfolio CI